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Abstract: Dentifrices containing H2O-reactive bioactive glasses alleviate hypersensitivity in
teeth via the blockage of open dentinal tubules. Here, the ability of two such products to
release Ca21 ions into human saliva was investigated, together with their influence on the
status of this biofluid’s 1H NMR-detectable biomolecules. Human salivary supernatants were
equilibrated with increasing volumes of those derived from each dentifrice (5.00 min at 378C).
These biofluids were also equilibrated at 378C with a preselected quantity of the intact
products (samples were collected at increasing timepoints). Salivary Ca21 concentrations were
monitored by a 1H NMR technique involving ethylenediamine tetra-acetate addition and/or
atomic absorption spectrometry. Added Ca
21
- and dentifrice supernatant volume (DSV)-
induced modifications to the salivary 1H NMR profile were explored by spectral titration. Data
acquired demonstrated added DSV-dependent increases in salivary Ca21 concentrations and
(Ca
21
-independent) modifications to the intensities of selected salivary
1
H NMR signals,
particularly those of the malodorous amines methyl-, dimethyl-, and trimethylamines, which
were diminished by up to 80% of their prior values. Time-dependent elevations in salivary
Ca
21
level were observed on equilibration with the intact dentifrices. Added Ca
21
ions exerted
a concentration-dependent influence on a range of resonances (including those of citrate,
succinate, pyruvate, and lactate). These data provide valuable information regarding the
mechanisms of action of the products tested. ' 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B:
Appl Biomater 91B: 88–101, 2009
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INTRODUCTION
Human tooth enamel remains highly susceptible to demin-
eralization in view of its recurrent exposure to saliva,
foods, and commonly consumed beverage drinks, the latter
of which often having low-pH values and contain Ca21
ion-chelating organic acids/anions, particularly citrate.
These processes leach essential tooth minerals and give rise
to an increased susceptibility to decay.1,2 Indeed, incipient
caries (i.e., very small enamel surface defects that are typi-
cally left untreated in the early stages) commonly arises
from such demineralization phenomena and may also occur
in patients with exposed regions of dentin, which derive
from decay below the cementum–enamel junction. In view
of these events, there has been a high level of research
work conducted aimed at slowing this natural process,
including the topical application of fluoride anion (F2),3 to-
gether with further agents.
This demineralization process gives rise to a time-de-
pendent cavitation of the enamel coating with a contingent
exposure of the underlying tooth structure. Such decay is
commonly treated by drilling out the decayed region and
the insertion of a semipermanent filling material. However,
there is clearly a major requirement for a less-invasive
pathway for the arrest and reversal of this process.
Although temporary prophylactic pit and fissure sealants
are now frequently used for the prevention of decay at par-
ticularly susceptible loci,4 such materials also require a fix-
ing agent and dry application and do not result in the
provision of an optimal level of sealing.5 Similarly, liner
and base materials are also used for the purpose of treating
newly exposed tooth surfaces, including those arising from
dental drilling. Indeed, such materials are designed and for-
mulated in order to diminish dentine permeability at the
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tooth-material interface6,7 and also offer protection against
microleakage from the filling material and its insertion site,
together with the sealing of dentinal tubules. Such materials
include (1) liners or cavity varnishes8 consisting of organic
gums, which remain subsequent to the evaporation of or-
ganic solvents in which they are dissolved prior to treat-
ment and (2) the stepwise application of a neutral oxalate
solution (e.g. K2[C2O4]) followed by an acidic one (e.g.,
one containing KH[C2O4]) to the layer.
9,10 However, many
disadvantages of the former (gum) treatment have been
revealed, such as acid vulnerability, junctional leakage, and
lack of adherence,11 and the latter (oxalate) process gives
rise to only a poor level of tubular seal occlusion.
Novel advances in the area of bone replacement materi-
als have led to the design and development of bioactive-,
biocompatible-glasses as agents for the induction and/or
facilitation of osteogenesis in physiological media.12 Indeed,
the bond-strength of the bone-glass junction has been shown
to be high and resistant against physiological attack/insult,13
and, to date, toxicological investigations have not revealed
any deleterious effects of these agents in bone and soft tis-
sue both in vitro and in vivo.14
Bioactive glasses comprise oxides of Ca21 and Na1, to-
gether with silicates and phosphates in a preselected pro-
portion that ensures surface activity and, synchronously,
the ability to chemically bond strongly to both teeth and
bone. Indeed, the applications of many bioactive glasses as
bone substitutes have been previously investigated in
detail.12,15,16
Phosphopeptides (isolated from a tryptic digest of casein
via aggregation with calcium phosphate and purified via
ultrafiltration)17 have the ability to stabilise nanoclusters of
amorphous calcium phosphate,18 whereas casein bioactive
glasses consisting of sodium calcium phosphosilicate deriv-
atives release Ca21 and phosphate ions in aqueous environ-
ments, a process giving rise to localized elevations in pH
and osmotic pressure.19 Indeed, exposed dentin can provide
a nucleation site for these ions, which locally generate
hydroxycarbonate apatite species.20
The mechanism for the process observed on exposure of
such bioactive glasses to aqueous biofluid systems primar-
ily involves an exchange of glass-containing Na1 ions with
protons (H1) therein, (e.g., those of human saliva) with a
synchronous elevation in pH value. Ca21 and phosphate
ions are then transferred from this material to form a sur-
face layer enriched with these species. Moreover, this pro-
cess involves a further layer that becomes increasingly
silicate-rich in view of the time-dependent removal of Na1,
Ca21, and phosphate ions from the glass.21–23
In studies involving the fabrication of replicated tooth
forms and their implantation into the pre-extracted incisor
sockets of adult baboons, Stanley et al.24 found that a bio-
active glass material significantly enhanced the attachment
of the implant to surrounding bone, as noted by histological
evaluation performed at a postimplant time-point of
6 months. Subsequent clinical investigations in humans have
revealed that bioactive glass granules are valuable agents for
the treatment of periodontal defects, together with further
hard tissue-based problems in the oral environment.25–29
However, the materials tested in the above investigations
did not demonstrate potential further advantages offered by
an agent, which combines a facile method of application
with tooth structure adherence, benefits which include the
ready penetration of extremely small tooth structure defects
and the longevity of both biophysical and biochemical
interactions with tooth structure following treatment. In
view of these critical, therapeutically important phenomena,
a novel bioactive glass formulation available for delivery in
selected dentifrices has been recently developed by Nova-
min Technology Incorporated (Alachua, FL). This agent
(NovaminR) consists of particles of \90 lm diameter (and
also contains a therapeutically effective remineralizing
content of those \10 lm) and was designed, formulated,
and developed with regard to its potential and/or estab-
lished therapeutic actions targeted at periodontal diseases,
including its ability to seal pits and/or fissures, promote
remineralization, line tooth structures, cap pulp, occlude
dentinal tubules, treat post-surgical tooth structure, and
provide an appropriate surface for the regeneration of tis-
sue. This bioactive glass therefore serves as a ‘‘carrier’’
for Ca21 and phosphate ions and is successful in maintain-
ing them in an ‘‘amorphous’’ state in selected dentifrice
products.
The therapeutic applications of such formulations are
also focused on dentine hypersensitivity, and a recent
investigation found that such products covered the surface
of dentine and/or occluded open dentinal tubules30 which,
according to Brannstrom and Atrom’s hydrodynamic hy-
pothesis,31 permit tubular fluid flow, a process giving rise
to changes in pressure, which excite dental pulp nerve end-
ings, and dentifrices containing bioglasses as active ingre-
dients provided a greater surface coverage and tubular
occlusion than those without these agents.32 Indeed, the
inclusion of bioactive glass particles in a selectively formu-
lated vehicle has proven to be an effective formulation for
the treatment of dentine hypersensitivity.33
This product has also been reported to exert bacterio-
static or bacteriocidal actions, a phenomenon probably
related to the change in pH induced by the dissolution of
the ions from the surface of the glass (as noted earlier) and
lack of bacterial adherence to the glass surface.34 Such
actions are also putatively ascribable to their ability to ele-
vate pH and osmotic pressure values at therapeutically rele-
vant sites (the dentogingival margin). Indeed, Stoor et al.35
also investigated the influence of a bioactive glass (S53P4)
on the viability of actinomycetumcomitans, Porphromonas
gingivalis, Streptococcus naeslundi, Strepococcus mutans,
and Streptococcus sanguis and found that suspensions of
this material exerted a broad spectrum of biocidal activity
toward both supra- and subgingival plaque microorganisms.
Hence, such agents may also offer carioststic benefits when
present in oral health care products.
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A further study36 examined the anti-gingivitis and anti-
plaque effects of a bioactive glass-containing dentifrice
against those of a control one and found that the former
product gave rise to significantly greater reductions in gin-
gival bleeding and supragingival plaque throughout a 6-
week study period.
Hence, these products offer valuable therapeutic advan-
tages over previously developed formulations, specifically
their facile application and rapid adherence to the tooth
structure. Indeed, such advantages involve their ability to
penetrate extremely small structural defects, together with
the occurrence of prolonged, therapeutically relevant bio-
chemical/biophysical interactions subsequent to their appli-
cation.
Results concerning the applications of high-field proton
(1H) NMR spectroscopy to the multicomponent analysis of
biomolecules (including inflammatory mediators) present in
complex biological fluids have been previously presented
(reviewed in Ref. 37). This technique offers many advan-
tages over alternative time-consuming, labor-intensive ana-
lytical methods since it permits the rapid, non-invasive, and
simultaneous study of a multitude of components present in
biofluids such as human saliva and generally requires little
or no knowledge of sample composition prior to analysis.
Moreover, chemical shift values, coupling patterns, and
coupling constants of resonances present in 1H NMR spec-
tra of such complex, multicomponent systems provide
much valuable molecular information regarding both en-
dogenous and exogenous chemical species detectable. The
broad overlapping resonances, which arise from macromo-
lecules present, are routinely suppressed by spin-echo pulse
sequences, giving rise to spectra which contain many sharp,
well-resolved signals attributable to a wide variety of low-
molecular-mass (non-protein-bound) components and the
mobile portions of macromolecules that are detectable at a
sensitivity of \5 3 1026 mol.dm23 (at an operating fre-
quency of 600 MHz) for samples not subjected to any form
of pre-concentration technique.
High-resolution NMR techniques have also been previ-
ously used to (1) index salivary biomolecules and supply
valuable metabolic data regarding intra- and inter-subject
variability in the salivary concentrations of a range of com-
ponents readily detectable by this technique, specifically or-
ganic acid anions and malodorous amines,38 and (2) probe
the complexation of Ca21 ions by low-molecular-mass sali-
vary biomolecules (results obtained revealed that the or-
ganic acid anion citrate acts as a powerful oxygen-donor
complexant for this metal ion).39
In this investigation, high-resolution, 1H NMR spectros-
copy has, for the first time, been used to evaluate the time-
dependent release of Ca21 ions from two novel bioactive
glass-containing dentifrices [products I (DenshieldeTooth-
paste) and II (OraviveR Tooth Revitalising Toothpaste),
Novamin Technology Incorporated] via the in vitro moni-
toring of salivary Ca21 concentrations, determined by
measurements of the intensity of the characteristic ethylenic
resonances of its complex with ethylenediamine tetra-ace-
tate (EDTA) present in the 1H NMR profiles acquired on
salivary supernatant samples treated with this chelator fol-
lowing equilibration with each product investigated (and/or
an alternative atomic absorption spectrometric method not
requiring pre-additon of this chelator). Modifications to the
1H NMR spectra of human salivary supernatants induced
by its equilibration (at 378C) with increasing added (micro-
liter) volumes of (1) supernatants derived from each denti-
frice product examined and (2) a standard, stock Ca21 ion
solution were also evaluated. Furthermore, salivary super-
natant specimens were equilibrated with pre-weighed quan-
tities of the (solid) dentifrices at this temperature in order
to monitor product- and time-dependent modifications to
salivary Ca21 ion concentrations (via the above techniques)
and to determine their influence on salivary 1H NMR pro-
files (samples were collected at increasing time-points).
The biochemical, clinical, and therapeutic significance of
the results acquired are discussed in detail.
MATERIALS AND METHODS
Materials
Products I and II (Denshielde and Oravive
R Tooth Revi-
talising Toothpastes respectively) were provided by Nova-
min Technology Incorporated, sodium dihydrogen citrate,
EDTA, sodium 3-trimethylsilyl[2,2,3,3-2H4] propionate
(TSP), and deuterium oxide (2H2O) were obtained from the
Sigma-Aldrich Chemical Co. (Milwaukee, WI), and cal-
cium chloride hexahydrate, and 10% (w/v) lanthanum chlo-
ride (LaCl3) solution were purchased from Fisher Scientific
(Loughborough, UK).
Sample Collection and Preparation
Each dentifrice was prepared for 1H NMR analysis via the
addition of 2.00 ml of doubly distilled H2O to 200 mg
samples by thorough rotamixing, centrifugation (3,500 rpm
for a 20-min. period) and removal of the clear supernatants.
Subsequently, further dentifrice supernatants derived from
the addition of 5.00 ml volumes of doubly distilled water
to either 249 mg of dentifrice I or 247 mg of dentifrice II,
followed by rotamixing and centrifugation as described ear-
lier were prepared and used for experiments involving their
addition to those derived from ‘‘whole’’ saliva specimens
as outlined below.
According to the manufacturers specifications, dentifrice
I contained (in order of decreasing content) glycerol, polye-
thyleneglycol, amorphous silica, calcium sodium phospho-
silicate (NovaminR), sodium lauryl sulphate, titanium
dioxide (TiO2), carbomer, potassium acesulfame, and fla-
voring components (anethole, eucalyptol, L-menthol, and
peppermint oil). Dentifrice II contained the same ingre-
dients in the above order, but with a much larger number
of flavouring agents (aldehyde C-9, anethole, anise oil,
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anise aldehyde, L-carvone, dihydrocarvone, dihydrocarvyl
acetate, eucalyptol, eucalyptus oil, eugenol, cis-3-hexenyl
iso-valeric acid, lime oil, L-menthol, L-menthone, ‘‘orange
juice carbonyls,’’ ‘‘orange terpenese,’’ peppermint oil,
spearmint oil, terpinene-4-ol, a-terineol, and vanillin). Den-
tifrices I and II contained 7.5 and 5.0% (w/w) NovaminR,
respectively, with a mean particle size of 12 lm for this
active agent in both products.
Unstimulated saliva samples were obtained from non-
medically-compromised healthy human volunteers (n 5 18)
with an age range of 22–49 years (mean age 6 standard
deviation 32.8 6 8.2 years). None of these volunteers had
any active periodontal disease or active dental caries. To
avoid any interferences arising from the introduction of ex-
ogenous and xenobiotic agents into the oral environment,
all volunteers were requested to collect all saliva available
(ca. 5–12 ml), i.e., ‘‘whole’’ saliva expectorated from the
mouth, into a plastic universal container immediately after
waking in the morning. Each volunteer was also asked to
completely abstain from oral activities (i.e., eating, drink-
ing, tooth-brushing and smoking) during the short period
between awakening and sample collection (\5 min) on the
morning of the study. Saliva samples were transported to
the laboratory on ice and immediately centrifuged on their
arrival to remove cells and debris. The supernatants were
then stored at 2708C for a maximum duration of 20 h
prior to NMR analysis.
Aliquots (6 3 0.50 ml) of each of a series of 5 human
salivary supernatant specimens with sufficient total volumes
([8.0 ml) were treated with 0.00, 0.02, 0.04, 0.06, 0.08,
and 0.10 ml volumes of the above dentifrice I supernatant,
followed by (0.10 2 x) ml of doubly distilled water [where
x 5 volume of dentrifrice supernatant added (ml)], whilst a
further 6 3 0.50 ml aliquots of each of the above group of
such salivary supernatants (n 5 5) were treated with
equivalent volumes of dentifrice II supernatant [0.00–
0.10 (x) ml] and correspondingly (0.10 2 x) ml of doubly-
distilled water.
In a further experiment, 12 3 0.50 ml aliquots of indi-
vidual samples from an additional group of human salivary
supernatants (n 5 6) with limited citrate concentrations
(i.e., little or no 1H NMR-detectable citrate) were each
treated with this biomolecule (final concentration 2.00 3
1024 mol.dm23), and the first and second sub-groups of six
of these were treated with 0.00, 0.02, 0.04, 0.06, 0.08, and
0.10 ml volumes of dentifrice I and II supernatants, respec-
tively [and subsequently, corresponding (0.10 2 x) ml vol-
umes of doubly-distilled water as described earlier]. Each
sample was thoroughly rotamixed prior to their preparation
for 1H NMR analysis (Sample Collection and Preparation
section). About 10–100 ll additions of each of the two
dentifrice supernatants tested were made to salivary super-
natants using a pre-calibrated micropipette.
Each of the above pre-treated salivary supernatant sam-
ples were then equilibrated at a temperature of 378C in a
water bath for a period of 5.00 min.
Determination of Salivary pH
After collection, the pH values of aliquots of each saliva
specimen were determined electrometrically using a Hanna
HI 1270 combination pH electrode and meter. The mean
(6 standard error, SE) pH value of human saliva samples
(n 5 18) prior to treatment with dentifrice supernatants
was 6.94 6 0.09 (range, 6.58–7.34).
Equilibration of Human Salivary Supernatants
with Untreated (Solid) Bioactive Glass
Dentifrice Formulations
For further salivary supernatant samples with sufficient vol-
umes available (n 5 5), 48 mg of dentifrice I or II was
added to individual 5.00 ml aliquots, the mixtures thor-
oughly rotamixed, and then equilibrated whilst shaking in a
water bath at 378C. 0.60 ml aliquots of these samples were
collected prior and immediately subsequent to dentifrice
addition and then at time-points of 30, 60, 90, 120, and
150 min. After collection, each aliquot was thoroughly cen-
trifuged and the supernatants removed for 1H NMR and/or
atomic absorption analysis.
NMR Measurements
Single-pulse 1H NMR spectra were acquired on a Bruker
Avance AM-600 spectrometer (Queen Mary University of
London facility) operating at a frequency of 600.13 MHz,
in quadrature detection mode and a probe temperature of
298 K. Each spectrum corresponded to 128 free induction
decays (FIDs) for control and dentifrice supernatant-treated
saliva samples, 5.6-ls pulses and a 1-s relaxation delay.
The intense H2O/HOD signal was effectively suppressed
via presaturation with gated decoupling during the delay
between pulses. Typically, 0.60 ml of each sample was
placed in a 5-mm diameter NMR tube, and 0.10 ml of a
2.50 3 1023 mol.dm23 solution of TSP (internal chemical
shift reference, d 5 0.00 ppm and quantitative 1H NMR
standard) in deuterium oxide (2H2O) was added, the latter
to provide a field frequency lock.
For salivary supernatant specimens, the methyl group res-
onances of acetate (s, d 5 1.920 ppm), alanine (d, d 5 1.487
ppm), and/or lactate (d, d 5 1.330 ppm) served as secondary
internal chemical shift references. The identities of biomole-
cules responsible for resonances present in the salivary 1H
NMR profiles acquired were routinely assigned by a consid-
eration of characteristic chemical shift values, coupling pat-
terns, and coupling constants. Where required, standard
additions of authentic compounds were made to confirm
assignments. Exponential line-broadening functions of 0.30
Hz were routinely used for the purpose of processing.
Acquisition of 1H-1H Correlation and Total
Correlation Spectra
1H-1H TOCSY spectra were acquired on the Bruker
Avance AX-600 spectrometer using the pulse sequence
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RD-(908-t1-spin lock)-ACQ,
40 908 on the Avance AX-600
spectrometer being equivalent to 8.4 ls for these experi-
ments. The spin-lock used the MLEV-17 sequence,41 with
a typical mixing time of 70 ms (for experiments in which a
restriction of carbon chain correlations was required, this
mixing time was only 20 ms). Acquisition parameters were
256 t1 increments, each of magnitude 2,048 data points,
spectral width 12,019 Hz in each dimension, 64 transients
in each case, four dummy scans, relaxation delay (RD) 3 s,
and acquisition time 0.17 s. Sine-bell-squared window
functions shifted by p/2 (i.e., a cosine squared function)
were applied in each dimension, with zero-filling twice in
f1, prior to transformation of the matrix of size 2,048 3
1,024 data points. The standard phase-sensitive (Time Pro-
portional Phase Incrementation) method42 was used for
optimal detection along the second dimension in these
experiments.
Two-dimensional shift-correlated 1H-1H COSY of
human salivary supernatants were also acquired on this
NMR facility using the standard sequence of Aue et al.,43
with 1,024 data points in the t2 dimension, 512 increments
of t1, a 2.00-s relaxation delay, and 16 transients.
Determination of Salivary Ca21 and Mg21
Concentrations by a Complexometric Method
Involving the 1H NMR Detection of Their
EDTA Complexes
Typically, 0.60 ml aliquots of human salivary supernatants
were treated with 0.09 ml of a 6.80 3 1021 mol.dm23 so-
lution of EDTA subsequent to their equilibration with the
above dentifrice formulation supernatants at 378C for 5.0
min. Salivary supernatants arising from experiments involv-
ing their equilibration with intact dentifrice products for
increasing time-periods were treated with EDTA in the
same manner. All samples were then equilibrated at an am-
bient temperature for a period of 30 min. prior to 1H NMR
analysis. The 600 MHz 1H NMR spectra of these EDTA-
treated samples were acquired in the manner described ear-
lier, and the singlet ethylenic group proton resonances of
free (uncomplexed) EDTA and its Ca21 and Mg21 com-
plexes (d 5 3.28, 2.57, and 2.76 ppm, respectively) were
electronically integrated, their intensities expressed relative
to that of the TSP internal standard (final concentration
3.57 3 1024 mol.dm23) and their concentrations deter-
mined, as previously described by Silwood et al.39 Alterna-
tively, salivary Ca21 and Mg21 levels were determined
from the ratios of the intensities of their ethylenic group
proton resonances to that of free EDTA, the latter’s final
added (total) concentration being 9.83 3 1023 and 1.176
3 1022 mol.dm23 for salivary supernatants directly treated
with those of the dentifrices tested, and those pre-equili-
brated with specified weights of the intact formulations at
378C for increasing periods of time, respectively.
Atomic Absorption Spectrometric Determination
of Salivary Ca21 Ion
About 0.60 or 1.00 ml aliquots of salivary supernatant sam-
ples collected at increasing time-points during their equili-
bration with pre-weighed quantities of the dentifrice
products tested were added to 0.10 ml of a 10.0% (w/v) so-
lution of LaCl3 in order to alleviate interferences from oxy-
anions, and the mixture was then diluted to a final volume
of 10.00 ml with doubly-distilled water. Ca21 concentra-
tions were determined on a Thermo Solaar S4 flame atomic
absorption spectrometer operating at a wavelength of 422.7
nm, a bandpass of 0.5 nm, an air-acetylene flame with an
acetylene flow-rate of 1.40 ml/min, and a sample uptake
rate of 5.00 ml.min21 with 4 s per reading and three re-
samples. A series of five CaCl2 calibration standards con-
taining 1.00, 2.00, 3.00, 4.00, and 5.00 mg.dm23 Ca21 and
the above (final) LaCl3 concentration [0.10% (w/v)] were
prepared and also analyzed using this technique, and plots
of signal absorbance versus Ca21 concentration were linear
(r 5 0.99975, p 5 4.83 3 1026).
RESULTS
High-Field, High-Resolution Proton NMR
Analysis of Human Saliva
1H NMR spectra (600 MHz) acquired on human salivary
supernatant specimens contained an abundance of promi-
nent, sharp resonances ascribable to a wide range of low-
molecular-mass components. Indeed, signals assignable to
short-chain organic acid anions, amino acids, and carbohy-
drates were readily observable, as previously described.38,44
In addition to considerations of chemical shift values, cou-
pling patterns, and coupling constants, together with com-
parisons with established literature values (making
allowances, where appropriate, for the analytical samples’
pH values and the pH-dependence of selected resonances
in spectra acquired therefrom), the identities of many of
these resonances were confirmed or supported by (1) the
acquisition of two-dimensional (2D) proton–proton (1H-1H)
COSY and TOCSY NMR spectra, and (2) treatment of the
salivary supernatants with standard additions of a range of
authentic, pure components (involving the addition of
microliter aliquots of 5.0 mM aqueous solutions), which
was particularly useful for ratifying components responsible
for signals arising from uncoupled nuclei (i.e., singlets), or
those with multiplets not readily detectable in either 1D or
2D spectra in view of their low concentrations.
The organic acid anions predominantly arise from mi-
crobial metabolism and hence these agents (either individu-
ally, or two or more in a multivariate sense) conceivably
represent chemotaxonomic markers of microbial activity in
the oral environment. Indeed, n-butyrate is produced
in large quantities by the pathogenic micro-organism P.
gingivalis.45
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Treatment of the salivary supernatants with those
derived from each oral health care product revealed that
agents present in the latter formulations were also readily
detectable in the 1H NMR spectra acquired. Indeed, the
results acquired demonstrated that each 1H NMR-respon-
sive component present in either dentifrice (glycerol, stea-
Figure 1. Expanded 2.10–3.50 ppm regions of 600.13 MHz single-pulse 1H NMR spectra of an unsti-
mulated salivary supernatant specimen treated with (a) 0 (untreated control), (b) 0.02, (c) 0.04, (d)
0.06, (e) 0.08, and (f) 0.10-ml aliquots of dentifrice I supernatant (and 0.10, 0.08, 0.06, 0.04, 0.02, and
0 ml of doubly distilled water, respectively), and (g) 0, (h) 0.02, (i) 0.04, (j) 0.06, (k) 0.08, and (l) 0.10 ml
of dentifrice II supernatant (and 0.10, 0.08, 0.06, 0.04, 0.02, and 0 ml of doubly distilled water, respec-
tively). Typical spectra are shown. Abbreviations: Ace K I, acesulfame K-CH3; Bu II and III, b-hydroxy-
butyrate b and b0 protons, respectively (ABX coupling system); n-But III, n-butyrate a-protons; Chol,
choline-N1(CH3)3; Cit, citrateCH2C(OH)(CO22)CH2 AB protons; DMA, dimethylamine-CH30s;
GABA I and II, c-amino-n-butyrate a- and c-CH2 protons, respectively; Glut I and II, glutamate b-and
c-CH2 protons, respectively; Glyc I SSB, glycerol-CCH2OH spinning sideband signal; MA, methyla-
mine-CH3; Meth, methanol-CH3; Phe I and II, phenylalanine ABX b- and a-protons, respectively; Pro I
and Pro II, proline b- and d-CH2 protons respectively; Prop II, propionate-CH2 group protons; Suc,
succinate-CH2; Tau I and II, taurine H3N
1CH2 and CH2SO32 protons, respectively; TMA, trime-
thylamine-CH3
0s; Try I, tryptophan b-CH2 protons; Tyr I and II, tyrosine ABX b protons.
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rate, sodium lauryl sulphate, and acesulfame) was readily
observable in the 1H spectra acquired with little or no inter-
ference from resonances arising from salivary components
(data not shown). As expected, the ratios of the electroni-
cally integrated intensities of each dentifrice component’s
1H NMR resonance to that of an added internal standard
increased linearly with added dentifrice supernatant volume
(DSV).
Clearly added dentifrice supernatant-induced modifica-
tions to the 1H NMR profiles of human saliva were also
observed (Figure 1). Indeed, particularly notable were
decreases in the intensities of resonances assigned to meth-
ylamine (s, d 5 2.61 ppm), dimethylamine (s, d 5 2.74
ppm), and trimethylamine (s, d 5 2.89 ppm), which were
clearly dependent on added DSV for both products investi-
gated here. Plots of the salivary concentrations of methyla-
mine and trimethylamine (determined from the TSP-
normalized 1H NMR resonance intensities of each of these
malodorous amines) versus added supernatant volume are
shown for each product in Figure 2: both mean 6 standard
Figure 1. (Continued )
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error (s.e.) data for the five salivary supernatant specimens
used for these experiments, and results for a typical sample,
are shown. These decreases in amine concentrations were
also observed in the salivary supernatant specimens equili-
brated for increasing periods of time with both of the intact
(solid) dentifrices, the magnitude of the reductions
observed increasing with increasing equilibration time,
especially at the lower time-points (data not shown).
As expected, equilibration of human salivary superna-
tants with those derived from each of the bioactive glass-
containing dentifrices examined here (as described in the
Materials and Methods section) also gave rise to detectable
modifications to the chemical shift values and AB system-
coupling patterns of salivary citrate resonances in speci-
mens in which this biomolecule was 1H NMR-detectable.
Indeed, for selected samples, addition of supernatants
obtained from either dentifrice product resulted in a down-
field shift of citrate’s A proton signal, and an upfield shift
for that of its B proton. However, for all samples with 1H
NMR-detectable citrate examined, there were small but
nevertheless significant broadenings of these resonances
(data not shown). These data are consistent with an
increase in its level of saturation by Ca21 ions, which are
released from the bioactive glass formulation present
therein.39 Similarly, the A and B citrate 1H resonances of
selected salivary supernatant samples that were pretreated
(i.e., ‘‘spiked’’) with this powerful Ca21 complexant (added
concentration 2.00 3 1024 mol.dm23) also displayed this
behavior following addition of increasing volumes of either
dentifrice supernatant (in view of the much higher [cit-
rate]:[Ca21] concentration ratios, the magnitude of such
shifts were much smaller than those observed with
untreated salivary supernatant specimens and were only
observable in 30% of samples investigated).
Treatment of control (untreated) salivary supernatant
samples with a final concentration of 9.83 3 1023 mol.dm23
EDTA, i.e., a concentration greater than that of salivary
Ca21 (mean level 1.55 3 1023 mol.dm23 39) gave rise to the
generation of intense ethylenic 1H NMR singlet resonances
located at 2.57 and 2.71 ppm attributable to its Ca21 and
Mg21 complexes, respectively; the corresponding signal of
free (uncomplexed) EDTA had a chemical shift value of
3.27 ppm (Figure 3). Moreover, spectra acquired on salivary
supernatants pre-treated with increasing microliter aliquots
of the supernatant derived from products I and II gave rise to
added volume (i.e., released Ca21 ion concentration)-
dependent elevations in the intensity of the ethylenic group
1H NMR resonance of the Ca26 EDTA complex, an observa-
tion accompanied by corresponding decreases in that of free
EDTA. Hence, these experimental data provide clear evi-
dence for dentifrice-mediated increases in salivary Ca21 ion
concentrations (Figure 3 reveals clear increases in the Ca26
EDTA: free EDTA resonance intensity ratio for a typical
sample pre-treated with a specified volume of each dentifrice
supernatant). Plots of salivary Ca21 concentration versus
volume of added dentifrice (lL) were clearly linear, typical
correlation coefficient (r) values being 0.9845 (p 5 3.57 3
1024) for product I and 0.9943 (p 5 4.82 3 1025) for prod-
uct II (Figure 4). The salivary Mg21 level remained inde-
pendent of added supernatant volume for both products
tested, an observation clearly indicating that no available
Mg21 ions are present in these media.
Figure 2. Plots of 1H NMR-determined salivary methylamine and tri-
methylamine concentrations versus added dentifrice supernatant
volume for products I and II. Results for a typical saliva specimen
are shown in (a) and (b) for products I and II, respectively, whereas
mean 6 SE values for all five samples used in these experiments
are exhibited in (c) and (d) (corresponding to products I and II,
respectively).
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For selected salivary supernatant specimens containing
citrate, or those pre-treated with this 1H NMR-detectable
Ca21 complexant (added concentration 2.00 3 1024
mol.dm3), modifications in the chemical shift values of
both the A and B protons of citrate’s two CH2 groups
were noted on addition of EDTA, the former to lower and
the latter to higher frequency. This observation was accom-
panied by the appearance of the relatively intense ethylenic
1H singlet resonance (d 5 2.57 ppm) attributable to the
Ca26 EDTA complex, an observation corresponding to the
complete transfer of Ca21 from citrate to the hexadentate
chelator EDTA. Following such treatment, the chemical
shift value of the citrate A and B 1H nuclei signals were
very similar to that of free, uncomplexed citrate.
Moreover, using the above 1H NMR/EDTA method for
the determination of salivary Ca21 levels (with a similar
added concentration of EDTA), clear time-dependent eleva-
tions were noted in this parameter following equilibration of
each of these intact dentifrice formulations with the 5 of the
18 human salivary supernatant samples of sufficient volume.
Indeed, plots of salivary Ca21 and Mg21 concentrations
versus equilibration time (Figure 5) revealed that for prod-
uct I there was an immediate rise of Ca21 level [from 0.57
to 0.90 3 1023 mol.dm23 for the example shown in Fig-
ure 5(a)] on addition of the dentifrice, a value which then
further increased to a maximum of 0.99 3 1023 mol.dm23
in the 60–90 min. time period and then slightly decreased
to 0.96 and 0.92 3 1023 mol.dm23 at 120 and 150 min.,
respectively. As noted for product I, addition of intact prod-
uct II to human salivary supernatants also gave rise to an
immediate elevation of supernatant Ca21 concentration [to
0.98 3 1023 mol.dm23 in the 1H NMR/EDTA-determined
example shown in Figure 5(b)], which then further
Figure 3. Estimation of salivary Ca21 and Mg21 ion concentrations
by the 1H NMR detection of their complexes with EDTA. Expanded
1.96–3.50 ppm regions of the 600.13 MHz 1H NMR spectra of a typ-
ical salivary supernatant sample (a) before and (b) after equilibration
with 0.10 ml of dentifrice I supernatant (and, correspondingly, 0 ml
of doubly-distilled water). Subsequent to equilibration, samples
were treated with EDTA [final added (total) concentration 9.83
mmol.dm23]. (c) and (d), as (a) and (b), respectively, but prior and
subsequent to equilibration of the sample with 0.10 ml of dentifrice
II supernatant. Typical spectra are shown. Abbreviations: as Figure
1, with EDTA-Ca21 and EDTA-Mg21 representing singlet signals
ascribable to the ethylenic group protons ([NCH2CH2N\) of
the Ca21 and Mg21 complexes of EDTA, respectively, and EDTA-E1
that of free (uncomplexed) EDTA.
Figure 4. (a) and (b): Plots of salivary Ca21 and Mg21 concentra-
tions versus volume of added dentifrice (ll) for products I and II,
respectively. Ca21 and Mg21 levels were determined by the 1H
NMR/EDTA method (Section 2). Typical results are shown.
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increased to a value of 1.30 3 1023 mol.dm23 after 30
min.; however, slow decreases in salivary Ca21 were also
noted during the 30–150 min time period.
For salivary supernatant samples subjected to Ca21 ion
determination by both the 1H NMR/added EDTA and
atomic absorption spectrometric techniques, there was an
excellent agreement between the two methods used. Table I
shows time-dependent percentage increases in salivary Ca21
concentration determined by both atomic absorption spec-
trometry and our 1H NMR technique for a typical salivary
supernatant sample equilibrated with intact products I and II
in the above series of experiments. As noted for the above
spectral titration experiments, the salivary Mg21 concentra-
tion was completely unaffected by equilibration at 378C
with both of the solid products, observations confirming
that, unlike Ca21, the dentifrices do not supply this metal
ion to human saliva.
In order to ascertain whether or not the added dentifrice
supernatant-dependent 1H NMR spectral modifications
noted in experiments involving the addition of increasing
volumes of each of the dentifrice supernatants to those aris-
ing from human saliva (Figures 1 and 2) were attributable
to Ca21 ions released from the products, we also performed
an investigation involving an 1H NMR titration of human
salivary supernatants with increasing added concentrations
of this metal ion (added level 0.00–14.30 mmol.dm23).
In addition to the Ca21 ion-mediated modifications to
the chemical shift values and coupling patterns of the sali-
vary citrate resonances observed, additional changes to the
1H NMR profiles of this biofluid were also noted for sam-
ples pretreated with increasing added concentrations of this
metal ion (Figure 6). These modifications included (1) sub-
stantial reductions in intensity or complete removal of the
succinate (CH2CH2) resonance (s, d 5 2.41 ppm),
an observation consistent with its involvement in Ca21
complexation, (2) significant decreases in that of the pyru-
vate-CH3 group (s, d 5 2.388 ppm) and glycine’s a-CH2
protons (s, d 5 3.59 ppm), with smaller reductions in sig-
nals ascribable to the methyl groups of 3-D-hydroxybutyrate
(d, d 5 1.24 ppm) and alanine (d, d 5 1.487 ppm), data
indicating their role in the chelation of added Ca21, and
(3) a marked broadening (and consequent reduction in
height) of the lactate-CH3 group resonance (d, d 5 1.330
Figure 5. Plots of salivary Ca21 and Mg21 concentrations versus
equilibration time for salivary supernatant specimens incubated with
untreated (solid) dentifrices I [(a) and (c)] and II [(b) and (d)] at 378C.
For (a) and (b), Ca21 and Mg21 levels were determined by the 1H
NMR/EDTA method, whereas for (c) and (d), Ca21 concentrations
were estimated by atomic absorption spectrometry (Section 2). Typi-
cal results are shown.
TABLE I. Comparison of Atomic Absorption (AAS)- and
1H NMR-Determined Percentage Increases in Ca21 Ion
Concentrations at Increasing Time-Points for a Typical Salivary
Supernatant Specimen Equilibrated with Intact (Solid)
Dentifrices I and II at 378C
Equilibration
Time (min.)









0 0 0 0 0
30 5.3 7.1 51.2 48.6
60 58.1 57.2 71.5 74.1
90 34.6 35.0 85.4 89.2
120 36.0 39.1 66.1 70.1
150 34.3 32.9 111.9 108.4
180 0.5 2.1 86.8 89.7
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ppm), together with an upfield shift (from 4.13 to 4.005
ppm at an added Ca21 concentrations of [8.60 mM) and
associated broadening of its CH proton quartet reso-
nance. Further modifications to the 1H NMR profiles of
human salivary supernatants arising from the addition of
increasing levels of Ca21 included a significant, reproduci-
ble broadening of the sharp singlet signal attributable to the
acetamido group methyl protons (NHCOCH3) of low-
molecular-mass N-acetylsugar species [e.g., N-acetylglucos-
amine and/or N-acetylneuraminate (sialate) present as mon-
osaccharides or small oligosaccharide species] (s, d 5 2.04
ppm)38 and elevations in choline’s N1(CH3)3 head-group
singlet resonance (d 5 3.20 ppm), a possible consequence
of its displacement from negatively charged protein bind-
ing-sites (putatively by positively charged Ca21-biomole-
cule complexes).
Notwithstanding, since the salivary methyl-, dimethyl-,
and trimethylamine 1H NMR signals were unaffected by
added Ca21 ion up to a level of 14.30 mmol.dm23, it
appears that both the solid dentifrice materials and water-
soluble components derived therefrom in corresponding
aqueous supernatants exert a unique means of removing
such malodorous metabolites from human saliva (the for-
mer by adsorption, i.e., physisorption), processes which
indicate their ability to combat and alleviate oral malodour.
DISCUSSION
1H NMR data acquired revealed significant elevations in
salivary Ca21 levels following treatment of supernatants
derived from this biofluid with calcium sodium phosphosili-
cate-containing dentifrices, an observation consistent with
their mechanism of action. Indeed, release of Ca21 ions
from the products tested here may effectively serve to di-
minish the quantity of open dentinal tubules in patients, a
parameter reflecting tooth hypersensitivity.
Although, as expected, there was a clear linear depend-
ence of increase in salivary Ca21 concentration on volume
of added dentifrice supernatant for both products investi-
gated, the time-dependence of this metal ion’s release from
the solid dentifrices into this biofluid matrix was more
complex. Indeed, for these experiments, the salivary Ca21
ion level increased to values approximately double their
initial, untreated (control) ones within a 90-min equilibra-
tion period at 378C and then decreased to a small extent
from 90 to 150 min for both products I and II. These sub-
sequent decreases in Ca21 ion concentration are not simply
explicable; however, they suggest a time-dependent shift in
the complex equilibria for this metal ion between solid so-
dium calcium phosphosilicate and a potentially very wide
range of solution-phase biomolecules with which it forms
complexes. Moreover, the stoichiometry and thermody-
namic stability constants of such complexes and the Ca21
ion saturation status of the complexants involved also rep-
resent further physiochemical considerations, as do the pH
and ionic strength values of the salivary supernatants exam-
ined here.
As expected, salivary Mg21 ion concentrations remained
unaffected by these dentifrices in both the supernatant titra-
tion and time-dependent equilibration experiments.
Data acquired also revealed that the 1H NMR signals of
malodorous salivary amines (methyl-, dimethyl-, and trime-
thylamines) were substantially diminished in intensity after
equilibration with increasing volumes of the dentifrice super-
natants or the specified added weights of the intact, untreated
Figure 6. Expanded 0.7223.30 ppm regions of 600.13 MHz single-
pulse 1H NMR spectra of an unstimulated salivary supernatant sam-
ple (a) before and (b) after treatment with Ca21ion (final added level
14.30 mmol.dm23). Typical spectra are shown. Abbreviations: as
Figure 1, with Ace, acetate-CH3; Ala, alanine-CH3; Bu I, 3-D-hydroxy-
butyrate-c-CH3 protons; iso-But I and II, iso-butyrate-b-CH3 and-a-
CH protons, respectively; n-But I, II, and III, n-butyrate-c-CH3,
-b-CH2, and c-CH2 protons, respectively; Eth, ethanol-CH3; Lac, lac-
tate-CH3; Leu I, II, and III, leucine d, c, and b protons, respectively;
N-Ac, acetamido-CH3 groups of free or low-molecular-mass oligo-
saccharide-containing N-acetylsugars (sharp signals)—the underlying
broader resonances are ascribable to hyaluronate N-acetylglucos-
amine residues and N-acetylneuraminate/N-acetylglucosamine sug-
ars present in the molecularly mobile carbohydrate side chains of
glycoproteins; Prop I, propionate-CH3 protons; Pyr, pyruvate-CH3;
Thr, threonine-CH3.
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solid products, an observation clearly indicating that such
species become ‘‘1H NMR-invisible’’ or are removable from
this biofluid medium by one or more available, partially or
wholly water-soluble components in the products tested.
Indeed, in the titration experiments performed with the prod-
uct supernatants, the decrease observed in amine resonance
intensities was clearly dependent on added volume (Figure
2). The process involved clearly does not involve the com-
plexation of released Ca21 ions by these salivary biomole-
cules since an 1H NMR spectral titration with increasing
added levels of this metal ion was found not to exert an influ-
ence the intensities of their resonances (Figure 6). Indeed,
the high pKa values of these species (10.66, 10.73, and 11.01
for methyl-, dimethyl-, and trimethylamine, respectively46),
would, of course, extremely limit their abilities to complex
Ca21 ions at physiological pH values.
In principle, polyethylene glycol present at high levels in
both dentifrice products may hydrogen (H)-bond to these
malodorous amines, a process, which, in view of the for-
mer’s polymeric nature, may substantially broaden their res-
onances and render them ‘‘1H NMR-invisible.’’ Moreover,
carbomer (a cross-linked polymer containing linear poly-
acrylate chains) may also exert this effect on the 1H NMR
resonances of these amines (which are fully protonated
under our experimental conditions, i.e., a mean salivary pH
value of 6.92 in this study) via their electrostatic binding to
negatively charged acrylate carboxylate groups of this
agent. A further, although less-plausible explanation
involves the formation of an ion-pair complex with the high
levels of dentifrice supernatant-containing lauryl sulphate,
with a fast exchange between the ‘‘free’’ and ‘‘bound’’
forms on the NMR timescale. Although the reaction of sali-
vary methylamine with aldehydes present in the flavoring
ingredients of product II to form one or more Schiff-base
adducts may also partially account for the decrease in inten-
sity of its 1H NMR signal, such reactive aldehydes were
absent from product I (and furthermore, they are only very
minor components present in product II).
With regard to salivary supernatant specimens equili-
brated with pre-weighed quantities of the intact (solid) den-
tifrice formulations, it is also plausible that solid-phase
polyethylene glycol and carbomer (i.e., those fractions
which remain water-insoluble during the 150-min equilibra-
tion period) bind these positively charged amines via
H-bonding or electrostatic interactions, respectively, at sali-
vary pH values. Moreover, negatively charged, solid-phase
silicate and phosphosilicate may also attract these amine
species and effectively remove them from the solution
phase via physisorption processes.
TMA present in the oral environment is potentially of
much importance regarding the aetiology of recalcitrant
oral malodour.47 Indeed, a low but nevertheless significant
proportion of subjects with this condition have an extra-
oral aetiology and, in view of its high level of volatility,
TMA can be delivered to exhaled air (and therefore saliva
in which it is also readily soluble) from the circulatory sys-
tem via the lungs. Hence, a further novel therapeutic activ-
ity of the two products tested here appears to be their
capacity to alleviate oral malodour.
Intriguingly, for these salivary supernatant specimens
equilibrated with the solid products I and II, the reductions
observed in the intensities of the 1H NMR resonances of
these salivary amines displayed a dependence on equilibra-
tion period for those samples treated with either dentifrice.
Although this time-dependence approximately correlated
with released Ca21 ion concentrations at the lower time-
points, as noted earlier, this metal ion did not exert an
influence on these singlet signals when independently
added to salivary supernatants up to a concentration of 14.3
mmol.dm23.
In addition to the previously documented influence of
added Ca21 ions on the 1H NMR resonances of salivary ci-
trate,39 spectral titration of human salivary supernatants
with increasing concentrations of this metal ion revealed
further modifications to the 1H NMR profiles of this bio-
fluid, specifically reductions in the intensities, increases in
the line-widths and/or changes in the chemical shift values
of a series of common salivary biomolecule resonances,
including those of succinate, pyruvate, lactate, 3-D-hydroxy-
butyrate, and low-molecular-mass N-acetylsugar species
[the release of positively charged choline from macromo-
lecular (e.g., protein) binding sites was also notable]. These
modifications to the salivary 1H NMR resonances are key
features, which provide valuable evidence for the involve-
ment of their corresponding biomolecules in the complexa-
tion/chelation of this added metal ion, as noted in our
previous investigations.39,48–52 Moreover, the ‘‘speciation’’
of Ca21 in this biofluid represents a phenomenon of much
relevance to demineralization/remineralization processes
and the pathogenesis of oral diseases in general. Indeed,
the extent of salivary biomolecule saturation with Ca21 is
of critical importance to tooth enamel erosion (superficial
losses of dental hard tissue via a chemical process that is
independent of microbial activity), the basic mechanism of
which involves a decrease in the degree of saturation of the
fluid surrounding the enamel with respect to calcium phos-
phate species.53 Therefore, selected biomolecular Ca21
complexants can effectively diminish the concentration of
‘‘free’’ (i.e., uncomplexed) Ca21 in saliva. Our further
observations regarding salivary Ca21 ion speciation and
their physicochemical and clinical significance will be
reported in detail elsewhere.
That added Ca21 up to a level of 14.3 mmol.dm23 did
not affect the methyl-, dimethyl-, and trimethylamine sig-
nals confirms that the marked reduction in their intensities
observed in salivary spectra with increasing added volume
of dentifrice supernatant, or time when this biofluid was
equilibrated at 378C with the solid, untreated products, con-
firmed that components other than released or releasable
Ca21 were responsible for this observation (the high pKa
values of these amines represents an important factor,
which serves as a barrier to their complexation of this
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metal ion at physiological pH values, as does the availabil-
ity of a wider range of oxygen donor atom-containing com-
plexants present at much higher salivary concentrations).
Bioactive glasses such as those present in the two prod-
ucts investigated here readily liberate-free Ca21 and phos-
phate ions in a time-dependent manner, a process
facilitating a reduction in the level of open dentinal tubules
in patients with tooth hypersensitivity and further oral dis-
eases involving these phenomena in their aetiology. More-
over, data obtained here describe, for the first time, the
facile application of high-resolution 1H NMR analysis to
the determination of bioactive-glass induced elevations in
salivary Ca21 concentrations subsequent to treatment with
dentifrices containing this novel, ‘‘smart’’ biomaterial. In
addition to confirming elevations in the concentration of
available salivary Ca21 following treatment with these
novel products, these data also revealed that, in at least
some of the samples examined, the degree of citrate satura-
tion with this metal ion is enhanced subsequent to such
treatment. As expected, this value was reduced to 0% on
the addition of excess levels of the Ca21 ion-chelator
EDTA; such a transfer of Ca21 is, of course, thermody-
namically favorable under our experimental conditions. In
principle, EDTA can also effectively remove Ca21 from al-
ternative salivary complexants such as phosphate, bicarbon-
ate, lactate, succinate, and pyruvate.
Elevations in salivary Ca21 levels (and also those of
phosphate) at exposed dentinal sites may serve to offer a val-
uable means for the arrest and, when in its primary stages,
reversal of tooth demineralization and hence dental caries.54
CONCLUSIONS
High-resolution 1H NMR analysis serves as a useful analyti-
cal tool for evaluating the mechanisms of action of dentifri-
ces containing H2O-reactive phosphosilicates, specifically
their concentration- and time-dependent release of Ca21ions
into human saliva, together with its therapeutic fate in this
biofluid (notably its complexation by salivary biomole-
cules): results acquired in this study indicate that for non-
protein-bound Ca21, salivary citrate, succinate, lactate, and
pyruvate can be used as probes for salivary Ca21 availabil-
ity. These observations provide valuable mechanistic infor-
mation regarding the therapeutically effective delivery of
this metal ion by the products tested to active sites involved
in the repair of caries-susceptible dentinal tubules. Data
obtained also provide evidence for the consumption of dele-
terious, malodorous salivary agents (methyl-, dimethyl-, and
trimethylamines) by further agents present in these denti-
frice products, an observation indicating that they offer an
additional mode of action (i.e., they appear to have the abil-
ity to combat halitosis).
The authors are very grateful to the Department of Biological
and Chemical Sciences, Queen Mary, University of London, for
the provision of NMR facilities.
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